We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
OC 9: Evaluation of the cost of care for cervical cancer in National Institute of Oncology at Rabat and the study of the possibility of establishing a flat-rate (forfait) for the management of this disease.
- Authors
Cheikh, A.; EL-Mejjaoui, S.; Ismaili, N.; Nejjari, C.; Cherrah, Y.; Benjaafar, N.
- Abstract
Introduction: The CCU is the seventh leading cause of cancer deaths in both sexes and the fourth most common cancer in women. The medical, social and economic consequences of CCU are very serious for households and for society. The study that we done is an economic evaluation (global cost) of the CCU in the National Institute of Oncology (NIO) in Rabat. It also aims to explore the possibility of establishment of flat-rate (forfait) of management of this disease depending on the stage in order to facilitate the management of patient records for the hospital, for patients and for the health insurance plan. Patients and Methods: 550 patients were followed and treated at NIO at Rabat for 1 year. Data of all medical and surgical services offered to patients were collected from the NIO registry. The unit costs and the overall cost of the care were calculated from the data on medical prestations lavished and recorded in patient records. The total direct cost of care was assessed using micro-costing method. The overall cost has been calculated on the basis of rates of health insurance and the real cost of each medical service. Results: The global cost for managing 550 patients, including all medical and surgical services, was about 12,867,053 MAD with an average estimated at 23,394.6 ± 7,549.8 MAD. Radiotherapy accounts for 55% of total costs, followed by curietherapy (27%) and surgery (7%). The overall cost of the treatment depends on the stage of the disease, this cost decreased significantly with the changing stages of CCU (r = -0.341, P < 0.001). Moreover, the four most important services, namely surgery, radiotherapy, curietherapy and chemotherapy, significantly influence the overall cost of care (P < 0.001). Discussion: The cost of care for patients with CCU within the NIO depends of stages of cancer. Referring to the results of our study, the standard deviations from the average costs are lower for stage IVA and IVB. In the early stages, that is, IB1, IIA, IIB and III, standard deviations are significant and important work to standardize medical practices should be undertaken within the NIO. This result should be taken into account in fixing the package of management CCU within the NIO.
- Subjects
MEDICAL care costs; CERVICAL cancer treatment; CANCER treatment
- Publication
Clinical Cancer Investigation Journal, 2015, Vol 4, Issue S1, pS17
- ISSN
2278-1668
- Publication type
Abstract